Hematologic Malignancies [clinicaltrials_resource:478da85698cef013001903abada26776]
IUdR/BUdR Cell Cycle Labelling [clinicaltrials:NCT00042250]clinicaltrials:NCT00058825clinicaltrials:NCT00061620clinicaltrials:NCT00079391clinicaltrials:NCT00086125Subcutaneously Administered CAMPATH in CD52 Expressing Hematologic Malignancies [clinicaltrials:NCT00113048]Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Streptococcal Sepsis After Hematopoietic Cell Transplantation [clinicaltrials:NCT00138112]Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation [clinicaltrials:NCT00144703]Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Blood Stem Cell Transplantation [clinicaltrials:NCT00146614]clinicaltrials:NCT00189488Haploidentical Transplantation With CD3/CD19 Depleted Grafts in Patients With Hematologic Malignancies [clinicaltrials:NCT00202917]Allogeneic Bone Marrow Transplantation With Matched Unrelated Donors for Patients With Hematologic Malignancies [clinicaltrials:NCT00208923]G-CSF PMRD: Granulocyte Colony Stimulating Factor (G-CSF) Stimulated Bone Marrow and In Vivo T-Cell Depletion in Patients With Hematologic Malignancies or Bone Marrow Failure Syndrome [clinicaltrials:NCT00228813]clinicaltrials:NCT00231309Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell Transplantation [clinicaltrials:NCT00355407]clinicaltrials:NCT00369226clinicaltrials:NCT00402714A Phase I/II Study of CP-4055 in Patients With Refractory/Relapsed Hematologic Malignancies [clinicaltrials:NCT00405743]clinicaltrials:NCT00429143clinicaltrials:NCT00429416clinicaltrials:NCT00469729A Phase I Trial of Myeloablative Conditioning w/ Clofarabine and HD Busulfan for Pts w/ Refractory Heme Malignancies Undergoing Allo PBSCT [clinicaltrials:NCT00477542]clinicaltrials:NCT00496340clinicaltrials:NCT00506857Adult Double Cord Blood Transplant Study [clinicaltrials:NCT00514579]clinicaltrials:NCT00521859A Single-arm Safety Study of Transplantation Using Umbilical Cord Blood and Human Placental-derived Stem Cells From Partially Matched Related Donors in Persons With Certain Malignant Blood Diseases and Non-malignant Disorders [clinicaltrials:NCT00596999]Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Patients With Advanced Hematologic Malignancies [clinicaltrials:NCT00642031]Safety Study of AP24534 to Treat Chronic Myelogenous Leukemia (CML) and Other Hematological Malignancies [clinicaltrials:NCT00660920]Infusion of Donor Lymphocytes Depleted of CD25+ Regulatory T-cells in Patients With Relapsed Hematologic Malignancies [clinicaltrials:NCT00675831]Safety Study of MultiStem® in Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplasia [clinicaltrials:NCT00677859]clinicaltrials:NCT00689884Nonmyeloablative Stem Cell Transplantation With CD8-depleted or Unmanipulated Peripheral Blood Stem Cells (PBSC) [clinicaltrials:NCT00693927]Study of MLN4924, a Novel Inhibitor of Nedd8 Activating Enzyme, in Adult Patients With Lymphoma or Multiple Myeloma [clinicaltrials:NCT00722488]In-Vitro Studies in Depletion of Haplotype Mismatched Alloreactive T Cells [clinicaltrials:NCT00731705]A Phase I Dose Escalation Study of Oral SB939 Administered Alone or With Azacitidine [clinicaltrials:NCT00741234]Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies [clinicaltrials:NCT00741455]Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC) [clinicaltrials:NCT00750737]Infusional C-myb ASODN in Advanced Hematologic Malignancies [clinicaltrials:NCT00780052]clinicaltrials:NCT00810602
condition [clinicaltrials_vocabulary:condition]
Hematologic Malignancies [clinicaltrials_resource:478da85698cef013001903abada26776]
Bio2RDF identifier
478da85698cef013001903abada26776
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:478da85698cef013001903abada26776
identifier
clinicaltrials_resource:478da85698cef013001903abada26776
title
Hematologic Malignancies
@en
label
Hematologic Malignancies [clinicaltrials_resource:478da85698cef013001903abada26776]
@en